Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 514 results for "Shionogi"

Purdue Pharma, Shionogi sign deal to market opioid-induced constipation drug
Fairfield Business Journal

Shionogi's EU HQ, by Resonate Interiors

Resonate Interiors creates Japanese pharmaceutical company Shionogi's European headquarters using bright colours and playful details. Choosing the round window may be synonymous with kids' TV for a certain generation brought up with Play School, ... On Office, 1 week ago

19 images for Shionogi

PharmaVOICE, 5 days ago
PharmaVOICE, 4 weeks ago, 1 month ago
Fairfield Business Journal, 4 weeks ago
Scrip Intelligence, 1 month ago
Scrip Intelligence, 1 month ago
Scrip Intelligence, 4 months ago
Scrip Intelligence, 4 months ago
Business Standard, 5 months ago
Business Standard India, 5 months ago

Shionogi announces positive results for Cefiderocol pivotal cUTI trial

Shionogi has announced that cefiderocol (S-649266), a novel siderophore cephalosporin in late-stage development, met the FDA pre-specified primary endpoint for non-inferiority vs imipenem/cilastatin (IPM/CS) in patients with serious complicated ...
 Center Watch1 day ago Shionogi Announces Positive TopLine Results For Cefiderocol Pivotal cUTI Clinical Trial  Pharma Focus Asia5 days ago Shionogi Release: Pharma's Investigators are Prepping a FDA App for New Antibiotic After Positive Trial  BioSpace5 days ago SHIONOGI : Announces Positive Top-Line Results For Cefiderocol Pivotal cUTI Clinical Trial  4 Traders6 days ago
European Pharmaceutical Review

ViiV Healthcare launches late-stage study of cabotegravir for prevention of HIV infection

ViiV Healthcare, the HIV-focused firm majority owned by GlaxoSmithKline ( GSK +0.1%), Pfizer ( PFE -0.7%)and Shionogi Limited ( OTC:SGIOF )( OTCPK:SGIOY ), commences a Phase 3 clinical trial to evaluate cabotegravir, a long-acting injectable ...
 Seeking Alpha4 weeks ago ViiV Healthcare's two-drug HIV regimen non-inferior to three/four-drug regimens in HIV maintenance  Seeking Alpha4 weeks ago ViiV Healthcare launch phase III study for injectable HIV treatment  Pharma Business International4 weeks ago ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention  4 Traders4 weeks ago

BRIEF-Shionogi & announces decision of patent revocation and patent infringement actions in UK

n"Nov 28 Shionogi & Co Ltd : * Says the co filed a counterclaim in patent court in the UK stating that Merck Sharp & Dohme Limited's "integrase inhibitor Isentress" infringes the co's UK patent on May 16, 2015 * Says on Nov. 25, patent court in ...
 Reuters UK1 month ago Patents of Interest That Could Lead to Business Developments  Legal Intelligencer3 weeks ago

Shionogi Partnering Deals and Alliances 2010-2016 - Research and Markets

Research and Markets has announced the addition of the "Shionogi Partnering Deals and Alliances 2010 to 2016" company profile to their offering. The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering ...
 4 Traders2 months ago Idiopathic Pulmonary Fibrosis Market Driver And Trends 2016 Analysis And Forecasts To 2020  Before It's News1 day ago Global Allergy Immunotherapies Market Size, Status and Forecast 2022  Press Release Ping1 week ago Global Head Lice Infestation Drug Market 2016 Share,Trend,Segmentation and Forecast to 2021  Before It's News3 weeks ago

Secondary Endpoint Data for S-033188, a Novel Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza, Support Favorable Primary Endpoint Data Previously Released

OSAKA, Japan, Dec. 1, 2016 /PRNewswire/ -- Shionogi & Co., Ltd. (hereafter "Shionogi") presented additional clinical data from a Phase 2 proof-of-concept study for S-033188, a cap-dependent endonuclease inhibitor targeting influenza. The primary ...
 4 Traders1 month ago

Shionogi : Participation in the global, multi-stakeholder collaboration, called Access Accelerated

22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases Global, multi-stakeholder collaboration, called Access Accelerated, to be delivered in partnership with World Bank Group ...
 4 Traders17 hours ago 22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases  International Business Times17 hours ago PhRMA Release: 22 Biopharma Companies Partner And Launch First-Of-Its-Kind Global Initiative To Address Rise Of Non-Communicable Diseases  BioSpace3 hours ago
Monthly Prescribing Reference

Novel Cephalosporin Demonstrates Superiority in Complicated UTI

Shionogi has announced positive results from the APEKs-cUTI* study which evaluated their novel antibiotic, cefiderocol (S-649266), for the treatment of patients with serious complicated urinary tract infection (cUTI) by
 Monthly Prescribing Reference5 days ago

UPDATE: Glaxo's ViiV Gets Positive HIV Study Results, Begins New Trial

ViiV is Glaxo's HIV joint venture with the US's Pfizer Inc and Japan's Shionogi & Co Ltd. Glaxo has a 76.5% stake in ViiV, whilst Pfizer holds 13.5% and Shionogi 10%. Glaxo said both of the phase 3 studies evaluating the safety and efficacy of ...
 London South East4 weeks ago TOP NEWS: Glaxo's ViiV Gets Positive Results On Two-Drug HIV Treatment  4 Traders4 weeks ago Glaxo's ViiV Gets Positive Opinion On Tivicay HIV Treatment  London South East1 month ago GLAXOSMITHKLINE : Glaxo's ViiV Gets Positive Opinion On Tivicay HIV Treatment  4 Traders1 month ago

Merck Sharp And Dohme Ltd v Shionogi & Co Ltd [2016] EWHC 2989 (Pat) (25 November 2016)

From [0099]-[0230] methods for use in the synthesis of the compounds of the invention are set out. None of this detail is material for present purposes. "[0232] The present invention is useful for preparing a pharmaceutical composition such as ...
 Bailii.org1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less